255 related articles for article (PubMed ID: 23723082)
1. Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation.
Kornblit B; Leisenring WM; Santos EB; Storb R; Sandmaier BM
Chimerism; 2013; 4(3):95-101. PubMed ID: 23723082
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
Mielcarek M; Storb R; Georges GE; Golubev L; Nikitine A; Hwang B; Nash RA; Torok-Storb B
Biol Blood Marrow Transplant; 2011 Feb; 17(2):214-25. PubMed ID: 20816818
[TBL] [Abstract][Full Text] [Related]
3. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.
Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R
Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
Chen Y; Fukuda T; Thakar MS; Kornblit BT; Storer BE; Santos EB; Storb R; Sandmaier BM
Cytotherapy; 2011 Nov; 13(10):1269-80. PubMed ID: 21846291
[TBL] [Abstract][Full Text] [Related]
5. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
6. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
[TBL] [Abstract][Full Text] [Related]
7. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
[TBL] [Abstract][Full Text] [Related]
8. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
[TBL] [Abstract][Full Text] [Related]
9. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
10. Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.
Georges GE; Storb R; Bruno B; Brodie SJ; Thompson JD; Taranova AG; Zaucha JM; Little MT; Zellmer E; Moore PF; Gooley T; Sale G; Kiem HP; Sandmaier BM; Lyons RM; Nash RA
Blood; 2001 Dec; 98(12):3447-55. PubMed ID: 11719387
[TBL] [Abstract][Full Text] [Related]
11. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
[TBL] [Abstract][Full Text] [Related]
12. A Canine Model of Chronic Graft-versus-Host Disease.
Graves SS; Rezvani A; Sale G; Stone D; Parker M; Rosinski S; Spector M; Swearingen B; Kean L; Storb R
Biol Blood Marrow Transplant; 2017 Mar; 23(3):420-427. PubMed ID: 28013013
[TBL] [Abstract][Full Text] [Related]
13. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
[TBL] [Abstract][Full Text] [Related]
14. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
Jochum C; Beste M; Zellmer E; Graves SS; Storb R
Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
[TBL] [Abstract][Full Text] [Related]
15. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
Graves SS; Hogan W; Kuhr CS; Diaconescu R; Harkey MA; Georges GE; Sale GE; Zellmer E; Baran SW; Jochum C; Stone B; Storb R
Blood; 2007 Jul; 110(1):418-23. PubMed ID: 17369487
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
[TBL] [Abstract][Full Text] [Related]
17. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R
Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051
[TBL] [Abstract][Full Text] [Related]
18. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
[TBL] [Abstract][Full Text] [Related]
19. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
20. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
